Answers are grounded in this paper and cite their sources.
ABU did not significantly affect BCG immunotherapy outcomes. Intravesical BCG during ABU is safe, with similar discontinuation rates, indicating very similar treatment tolerability.
No takes yet. Share an insight, caveat, or question.
Nummi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: